These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19404778)

  • 1. The expression and prognosis of FOXO3a and Skp2 in human hepatocellular carcinoma.
    Lu M; Ma J; Xue W; Cheng C; Wang Y; Zhao Y; Ke Q; Liu H; Liu Y; Li P; Cui X; He S; Shen A
    Pathol Oncol Res; 2009 Dec; 15(4):679-87. PubMed ID: 19404778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression and prognosis of FOXO3a and Skp2 in human ovarian cancer.
    Lu M; Zhao Y; Xu F; Wang Y; Xiang J; Chen D
    Med Oncol; 2012 Dec; 29(5):3409-15. PubMed ID: 22714061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
    Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
    Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
    Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
    Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Akt/FoxO3a/Skp2 Axis Is Critically Involved in Berberine-Induced Cell Cycle Arrest in Hepatocellular Carcinoma Cells.
    Li F; Dong X; Lin P; Jiang J
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29360760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression and significance of pThr32-FOXO3a in human ovarian cancer.
    Lu M; Xiang J; Xu F; Wang Y; Yin Y; Chen D
    Med Oncol; 2012 Jun; 29(2):1258-64. PubMed ID: 21452041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear expression of S-phase kinase-associated protein 2 predicts poor prognosis of hepatocellular carcinoma.
    Shin E; Kim SH; Jeong HY; Jang JJ; Lee K
    APMIS; 2012 May; 120(5):349-57. PubMed ID: 22515289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a.
    Cao MQ; You AB; Zhu XD; Zhang W; Zhang YY; Zhang SZ; Zhang KW; Cai H; Shi WK; Li XL; Li KS; Gao DM; Ma DN; Ye BG; Wang CH; Qin CD; Sun HC; Zhang T; Tang ZY
    J Hematol Oncol; 2018 Jan; 11(1):12. PubMed ID: 29361949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Forkhead Box O3a and Its Association With Aggressive Phenotypes and Poor Prognosis in Human Hepatocellular Carcinoma.
    Ahn H; Kim H; Abdul R; Kim Y; Sim J; Choi D; Paik SS; Shin SJ; Kim DH; Jang K
    Am J Clin Pathol; 2018 Jan; 149(2):117-127. PubMed ID: 29365018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression and prognosis of Emi1 and Skp2 in breast carcinoma: associated with PI3K/Akt pathway and cell proliferation.
    Liu X; Wang H; Ma J; Xu J; Sheng C; Yang S; Sun L; Ni Q
    Med Oncol; 2013 Dec; 30(4):735. PubMed ID: 24277465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aurora-A/FOXO3A/SKP2 axis promotes tumor progression in clear cell renal cell carcinoma and dual-targeting Aurora-A/SKP2 shows synthetic lethality.
    Li P; Chen T; Kuang P; Liu F; Li Z; Liu F; Wang Y; Zhang W; Cai X
    Cell Death Dis; 2022 Jul; 13(7):606. PubMed ID: 35831273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foxo3a transcription factor is a negative regulator of Skp2 and Skp2 SCF complex.
    Wu J; Lee SW; Zhang X; Han F; Kwan SY; Yuan X; Yang WL; Jeong YS; Rezaeian AH; Gao Y; Zeng YX; Lin HK
    Oncogene; 2013 Jan; 32(1):78-85. PubMed ID: 22310285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic trioxide-induced growth arrest of human hepatocellular carcinoma cells involving FOXO3a expression and localization.
    Fei M; Lu M; Wang Y; Zhao Y; He S; Gao S; Ke Q; Liu Y; Li P; Cui X; Shen A; Cheng C
    Med Oncol; 2009; 26(2):178-85. PubMed ID: 18937079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
    Fang L; Wang H; Zhou L; Yu D
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of S-phase kinase-associated protein 2-mediated p27 degradation suppresses tumorigenesis and the progression of hepatocellular carcinoma.
    Qi M; Liu D; Zhang S; Hu P; Sang T
    Mol Med Rep; 2015 May; 11(5):3934-40. PubMed ID: 25572801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of FOXJ1 in hepatocellular carcinoma: correlation with patients' prognosis and tumor cell proliferation.
    Chen HW; Huang XD; Li HC; He S; Ni RZ; Chen CH; Peng C; Wu G; Wang GH; Wang YY; Zhao YH; Zhang YX; Shen AG; Wang HM
    Mol Carcinog; 2013 Aug; 52(8):647-59. PubMed ID: 22488567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation.
    Wang F; Chan CH; Chen K; Guan X; Lin HK; Tong Q
    Oncogene; 2012 Mar; 31(12):1546-57. PubMed ID: 21841822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes?
    Huang CW; Lin CY; Huang HY; Liu HW; Chen YJ; Shih DF; Chen HY; Juan CC; Ker CG; Huang CY; Li CF; Shiue YL
    Ann Surg Oncol; 2010 Mar; 17(3):907-22. PubMed ID: 19866239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of miR-155 on proliferation and apoptosis by regulating FoxO3a/BIM in liver cancer cell line HCCLM3.
    Liao WW; Zhang C; Liu FR; Wang WJ
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1277-1285. PubMed ID: 29565484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SKP2 Promotes Hepatocellular Carcinoma Progression Through Nuclear AMPK-SKP2-CARM1 Signaling Transcriptionally Regulating Nutrient-Deprived Autophagy Induction.
    Wei X; Li X; Yan W; Zhang X; Sun Y; Zhang F
    Cell Physiol Biochem; 2018; 47(6):2484-2497. PubMed ID: 29991055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.